Keywords: نسبت خطر; atrial fibrillation; cardiac surgery; ASCERT; American College of Cardiology Foundation-Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies; AF; atrial fibrillation; CABG; coronary artery bypass gr
مقالات ISI نسبت خطر (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: نسبت خطر; AKI; acute kidney injury; BMI; body mass index; CHF; congestive heart failure; CMS; Centers for Medicare & Medicaid Services; COPD; chronic obstructive pulmonary disease; CV; cardiovascular; eGFR; estimated glomerular filtration rate; ESRD; end-stage rena
Keywords: نسبت خطر; BMI; body mass index; HR; hazard ratio; NHANES III; the Third National Health and Nutrition Examination Survey; OR; odds ratio; WC; waist circumference;
Keywords: نسبت خطر; NSCLC; non-small cell lung cancer; RCTs; randomized controlled trials; OS; overall survival; PFS; progression free survival; ORR; objective response rate; AEs; adverse effects; HR; hazard ratio; RR; relative risk; CI; confidence intervals; FDA; Food and D
Keywords: نسبت خطر; CI; confidence interval; CRLM; colorectal cancer liver metastases; 18F-FDG; 18F-fluorodeoxyglucose; HR; hazard ratio; LTD; longest tumor diameter; NTL; nontarget lesion; OS; overall survival; PET; positron emission tomography; RE; radioembolization; RECIS
Keywords: نسبت خطر; CI; confidence interval; ESD; endoscopic submucosal dissection; HCC; hepatocellular carcinoma; HR; hazard ratio;
Keywords: نسبت خطر; Benefit and risk assessment; Intake estimates; Potassium; Sodium; Vulnerable groups; ACE; angiotensin-converting enzyme; AI; adequate intake; CI; confidence interval; CVD; cardiovascular disease; FFQ; food frequency questionnaire; HR; hazard ratio; KCl; p
Keywords: نسبت خطر; bifurcation lesion; left main coronary artery; percutaneous coronary intervention; ACS; acute coronary syndrome(s); CABG; coronary artery bypass; C-DES; current-generation drug-eluting stent(s); CI; confidence interval; CKD; chronic kidney disease; DES; d
Keywords: نسبت خطر; AE; adverse event; AUC; area under the curve; CI; confidence interval; Cmax; maximum concentration; HCC; hepatocellular carcinoma; HR; hazard ratio; OS; overall survival; PK; pharmacokinetic; PVA; polyvinyl alcohol; TTP; time to progression; W/O; water-in
Keywords: نسبت خطر; F34; F37; F38; F44; F62; Sovereign; Defaults; Hazard ratio; Survival analysis; Crisis;
Keywords: نسبت خطر; new-generation drug-eluting stents; patient-level pooled analysis of women; percutaneous coronary intervention; stent length per lesion; stent length per patient; CI; confidence interval; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); HR; ha
Keywords: نسبت خطر; Essential Trace Elements; Dietary Intake; Esophageal Cancer; Dose-Response; Meta-Analysis; BMI; body mass index; CI; confidence interval; DHQ; Dietary History Questionnaire; EAC; esophageal adenocarcinoma; ESCC; esophageal squamous cell cancer; FFQ; Foo
Keywords: نسبت خطر; bacteremia; newborn; invasive infections; meningitis; BSI; Bloodstream infection; CLABSI; Central line-associated bloodstream infection; CoNS; Coagulase-negative staphylococci; E coli; Escherichia coli; EOS; Early-onset neonatal sepsis; GBS; Group B Strep
Keywords: نسبت خطر; endocarditis; mitral valve surgery; mitral valve repair; mitral valve replacement; ASMD; absolute standardized mean difference; CI; confidence interval; HR; hazard ratio; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modific
Keywords: نسبت خطر; ADL; Activities of Daily Living; BDNF; Brain-Derived Neurotrophic Factor; CBF; Cerebral Blood Flow; CI; Confidence Interval; CNS; Central Nervous System; COX; Cyclooxygenase; CSF; Cerebro-Spinal Fluid; DES; Depression-Executive Dysfunction Syndrome; DST c
Keywords: نسبت خطر; lung; non-small cell lung cancer; orthotopic animal model; tumor microenvironment; ELISA; enzyme-linked immunosorbent assay; FCS; fetal calf serum; GFP; green fluorescent protein; H460; human 460 lung cancer cell line; HPRT1; hypoxanthine phosphoribosyl
Keywords: نسبت خطر; Hazard ratio; Instantaneous rate; Relative rate; Relative risk; Cox proportional hazards regression model;
Keywords: نسبت خطر; Preoperative Therapy; Immune Checkpoint Inhibitors; HER2 Targeted Therapy; VEGF Targeted Therapy; ECF; epirubicin, cisplatin, and 5-FU; EGFR; epidermal growth factor receptor; FLOT; 5-FU and oxaliplatin; 5-FU; 5-fluorouracil; GEJ; gastroesophageal junctio
Keywords: نسبت خطر; Colon Cancer; Marker; Microbiome; Pathogen; CDARS; Clinical Data Analysis and Reporting System; CI; confidence interval; CRC; colorectal cancer; HR; hazard ratio; IL; interleukin;
Keywords: نسبت خطر; ADA; American Diabetes Association; CI; Confidence interval; Finnish DPS; Finnish Diabetes Prevention Study; HR; Hazard ratio; IDPP-1; Indian Diabetes Prevention Programme; IFG; Impaired fasting glucose; IGT; Impaired glucose tolerance; QALY; Quality-adju
Keywords: نسبت خطر; furosemide; loop diuretic; congenital heart disease; fractures; CHD; Congenital heart defect; HR; Hazard ratio; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; MPR; Medication possession ratio; PPIs; Proton pump
Keywords: نسبت خطر; bariatric; cardiovascular risk; diabetes; metabolic; obesity; AGB; adjustable gastric banding; BMI; body mass index; BPD; biliopancreatic diversion; BPDDS; biliopancreatic diversion with duodenal switch; CI; confidence interval; HbA1c; glycated hemoglobin
Keywords: نسبت خطر; 6MWT; 6-Minute Walk Test; AACE; American Association of Clinical Endocrinologists; ACE; American College of Endocrinology; ADT; androgen deprivation therapy; BMI; body mass index; BRS; baroreflex sensitivity; CAC; coronary artery calcium; CAD; coronary ar
Keywords: نسبت خطر; anticoagulation; antiplatelet; antithrombotic therapy; peripheral artery disease; risk reduction; ABI; ankle-brachial index; HR; hazard ratio; MACCE; major adverse cardiovascular or cerebrovascular events; MALE; major adverse limb events; NNT; number need
Keywords: نسبت خطر; BP; blood pressure; BMI; body mass index; CVD; cardiovascular disease; CI; confidence interval; FPG; fasting plasma glucose; FDR; first-degree relatives; HbA1c; glycosylated hemoglobin; HDLC; high density lipoprotein cholesterol; HC; hip circumference; HR
Keywords: نسبت خطر; Hand strength; Leg strength; Death; Muscles; HR; hazard ratio; PRISMA; Preferred Reporting Items for Systematic Reviews and Meta-Analyses;
Keywords: نسبت خطر; biodegradable polymers; bioresorbable vascular scaffold; bleeding; drug-eluting stent; percutaneous coronary intervention; stent restenosis; stent thrombosis; 1G-DES; first-generation drug-eluting stent(s); 2G-DES; second-generation drug-eluting stent(s);
Keywords: نسبت خطر; ACC; American College of Cardiology; AHA; American Heart Association; HF; Heart failure; COPD; Chronic obstructive pulmonary disease; HR; Hazard ratio; HbA1c; Glycosylated hemoglobin A1c; ICD-9; International Classification of Diseases, Ninth Revision; IC
Keywords: نسبت خطر; diabetes mellitus; metformin; skin cancer; Taiwan; HR; hazard ratio; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; NHI; National Health Insurance; NMSC; nonmelanoma skin cancer; PS; propensity score; UV; ultrav
Keywords: نسبت خطر; Epidemiology; Reflux Treatment; Cardiovascular Disease; Drug; BMI; body mass index; CI; confidence interval; GERD; gastroesophageal reflux disease; GI; gastrointestinal; H2RA; histamine-2 receptor antagonist; HPFS; Health Professionals Follow-up Study; HR
Keywords: نسبت خطر; mitral valve surgery; postoperative atrial fibrillation; AF; atrial fibrillation; AV; aortic valve; CARD; Cardiovascular Research Database; CI; confidence interval; DMR; degenerative mitral regurgitation; HR; hazard ratio; MV; mitral valve; PS; propensity
Keywords: نسبت خطر; Platelet-to-lymphocyte ratio (PLR); Prognosis; Advanced cancer; Meta-analysis; PLR; platelet-to-lymphocyte ratio; OS; overall survival; PFS; progression-free survival; DFS; disease-free survival; CSS; cancer-specific survival; MeSH; Medical Subject Headin
Keywords: نسبت خطر; ACSD; Adult Cardiac Surgery Database; BITA; bilateral internal thoracic arteries; CABG; coronary artery bypass graft surgery; CI; confidence interval; CRI; completeness of revascularization index; DM; diabetes mellitus; HR; hazard ratio; LAD; left anterio
Keywords: نسبت خطر; Atrial fibrillation burden; Diagnosis; Clinical outcomes; Anticoagulation; AF; atrial fibrillation; AHRE; atrial high rate episode; CI; confidence interval; CIED; cardiac implantable electronic device; CRT; cardiac resynchronization therapy; ECG; electroc
Keywords: نسبت خطر; Immunoassay; Serum biomarker; Cancer; Follow-up; Prognosis; Histotype; HE4; human epididymis protein 4; OC; ovarian cancer; CA125; carbohydrate antigen 125; HR; hazard ratio; PFS; progression-free survival; NCCN; National Comprehensive Cancer Network; GCI
Keywords: نسبت خطر; AKI; acute kidney injury; CHF; congestive heart failure; CI; confidence interval; CKD; chronic kidney disease; eGFR; estimated glomerular filtration rate; EuroSCORE; European System for Cardiac Operative Risk Evaluation; HR; hazard ratio; MI; myocardial i
Keywords: نسبت خطر; Colorectal Cancer; Microsatellite Instability; Tumorigenic Process; Driver Gene Mutations; Positive and Negative Selection; bp; base pair; CRC; colorectal cancer; HR; hazard ratio; indel; insertion/deletion; MLH1; MutL Homolog 1; MMR; mismatch repair; mRN
Keywords: نسبت خطر; aHR; adjusted hazard ratio; BMI; body mass index; CI; confidence interval; GP; general practitioner; HR; hazard ratio; iHOPE; Incident Health Outcomes and Psoriasis Event; NAFLD; nonalcoholic fatty liver disease; PsA; psoriatic arthritis; PsO; psoriasis;
Keywords: نسبت خطر; heart failure with preserved ejection fraction; risk-score; perioperative management; risk evaluation; cardiac surgery; AUROC; receiver operating characteristics area under the curve; BNP; brain natriuretic peptide; CABG; coronary artery bypass graft; ESC
Keywords: نسبت خطر; AJCC; American Joint Committee on Cancer; BSC; basaloid squamous cell carcinoma; HR; hazard ratio; OS; overall survival; SEER; Surveillance Epidemiology and End Results; SqCC; squamous cell carcinoma;
Keywords: نسبت خطر; BCC; basal cell carcinoma; CI; confidence interval; HR; hazard ratio; MAL; methyl aminolevulinate; PDT; photodynamic therapy; sBCC; superficial basal cell carcinoma;
Keywords: نسبت خطر; HDP; hypertensive disorders of pregnancy; GH; gestational hypertension; PE; preeclampsia; AT1; type-1 angiotensin II receptor; HF; heart failure; NP; natriuretic peptide; BNP; B-type natriuretic peptide; NT-proBNP; N-terminal pro-B-type natriuretic peptid
Keywords: نسبت خطر; 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: نسبت خطر; Teenager; Youth; Prevention; Colon; BMI; body mass index; HR; hazard ratio; ICD; International Classification of Diseases; NPR; National Patient Register;
Keywords: نسبت خطر; Cardiovascular prognosis; Airflow limitation; COPD; Diastolic function; Hypoxemia; Outpatients; BMI; Body Mass Index; BNP; type-B Natriuretic Peptide; COPD; Chronic Obstructive Pulmonary Disease; DLCO; Carbon monOxide Lung Diffusing capacity corrected for
Keywords: نسبت خطر; aspirin; melanoma; platelets; stage; survival; treatment; CPH; Cox proportional hazards; CI; confidence interval; HR; hazard ratio; TGFβ; transforming growth factor-β;
Keywords: نسبت خطر; PIB; Progression in Barrett's Esophagus score; Multi-Center Trial; Esophageal Cancer; BE; Barrett's esophagus; BEST; Barrett's Esophagus Study; CI; confidence interval; EAC; esophageal adenocarcinoma; HGD; high-grade dysplasia; HR; hazard ratio; LGD
Keywords: نسبت خطر; Obstructive sleep apnea (OSA); Continuous positive airway pressure (CPAP); Humidifier; Adherence; Gender; BMI; aRRR; adjusted relative risk ratio; AHI; apnea-hypopnea index; BMI; body mass index; CI; confidence interval; CPAP; continuous positive airway p
Keywords: نسبت خطر; AA; alopecia areata; AS; ankylosing spondylitis; CD; Crohn's disease; CI; confidence interval; HR; hazard ratio; ICD-10; 10th revision of the International Statistical Classification of Diseases and Related Health Problems; UC; ulcerative colitis; TNF;
Keywords: نسبت خطر; AE; adverse event; ADR; adverse drug reaction; ANC; absolute neutrophil count; CI; confidence interval; CR; complete remission; CTCAE; common terminology criteria for adverse events; DEX; dexamethasone; ECOG; eastern cooperative oncology group; eCRF; elec